Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia
Author(s) -
Eduardo Seclén,
María del Mar González,
Carmen de Mendoza,
Vincent Soriano,
Eva Poveda
Publication year - 2010
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq156
Subject(s) - maraviroc , tropism , tissue tropism , context (archaeology) , virology , antiretroviral therapy , medicine , immunology , ccr5 receptor antagonist , viral load , human immunodeficiency virus (hiv) , biology , virus , chemokine , immune system , chemokine receptor , paleontology
The use of maraviroc as part of a simplification of antiretroviral therapy (ART) is hampered by the difficulty of assessing viral tropism in patients with undetectable viraemia. In this context, information on tropism might be obtained from testing either older stored viraemic sera collected before initiation of ART or current proviral DNA in peripheral blood cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom